OBJECTIVE: Giant cell arteritis (GCA) is commonly known for its clinical presentation of temporal arteritis. However, GCA affects large arteries, predominantly the aorta and its proximal branches, in up to 75% of cases. We describe the clinical presentation and diagnostic test results of patients with large-vessel GCA. METHODS: Case description of 11 patients with large-vessel GCA diagnosed consecutively in our hospital. RESULTS: The clinical presentation of large-vessel GCA is highly variable, from systemic inflammation to aortic rupture. Imaging shows variable abnormalities, but 18-fluorodeoxyglucose positron-emission-tomography (18-FDG PET) seems to be a sensitive and reasonably specific diagnostic test for large-vessel GCA. CONCLUSION: Large-vessel GCA is a clinically heterogeneous condition. 18-FDG PET should be considered in the diagnostic work-up of suspected cases. Since this disorder has a high complication rate, and is responsive to treatment with corticosteroids, a high level of clinical suspicion is warranted.
OBJECTIVE: Giant cell arteritis (GCA) is commonly known for its clinical presentation of temporal arteritis. However, GCA affects large arteries, predominantly the aorta and its proximal branches, in up to 75% of cases. We describe the clinical presentation and diagnostic test results of patients with large-vessel GCA. METHODS: Case description of 11 patients with large-vessel GCA diagnosed consecutively in our hospital. RESULTS: The clinical presentation of large-vessel GCA is highly variable, from systemic inflammation to aortic rupture. Imaging shows variable abnormalities, but 18-fluorodeoxyglucose positron-emission-tomography (18-FDG PET) seems to be a sensitive and reasonably specific diagnostic test for large-vessel GCA. CONCLUSION: Large-vessel GCA is a clinically heterogeneous condition. 18-FDG PET should be considered in the diagnostic work-up of suspected cases. Since this disorder has a high complication rate, and is responsive to treatment with corticosteroids, a high level of clinical suspicion is warranted.
Authors: Petra Lehmann; Sarah Buchtala; Nelli Achajew; Peter Haerle; Boris Ehrenstein; Hamid Lighvani; Martin Fleck; Joerg Marienhagen Journal: Clin Rheumatol Date: 2010-10-23 Impact factor: 2.980
Authors: Sebastian H Unizony; Bhaskar Dasgupta; Elena Fisheleva; Lucy Rowell; Georg Schett; Robert Spiera; Jochen Zwerina; Olivier Harari; John H Stone Journal: Int J Rheumatol Date: 2013-04-07
Authors: Enrico Ammirati; Francesco Moroni; Patrizia Pedrotti; Isabella Scotti; Marco Magnoni; Enrica P Bozzolo; Ornella E Rimoldi; Paolo G Camici Journal: Front Immunol Date: 2014-08-18 Impact factor: 7.561
Authors: Karel-Jan D F Lensen; Alexandre E Voskuyl; Conny J van der Laken; Emile F I Comans; Dirkjan van Schaardenburg; Alex B Arntzenius; Ton Zwijnenburg; Frank Stam; Michelle Gompelman; Friso M V D Zant; Anneke Q A van Paassen; Bert J Voerman; Frits Smit; Sander Anten; Carl E Siegert; Arjen Binnerts; Yvo M Smulders Journal: PLoS One Date: 2013-03-19 Impact factor: 3.240
Authors: Menno D Stellingwerff; Elisabeth Brouwer; Karel-Jan D F Lensen; Abraham Rutgers; Suzanne Arends; Kornelis S M van der Geest; Andor W J M Glaudemans; Riemer H J A Slart Journal: Medicine (Baltimore) Date: 2015-09 Impact factor: 1.817